ASPARTIC ACID

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
132.0 -4.5 1 4 108.0 3 0.5
UNII
30KYC7MIAI
CAS
56-84-8
NAME
  • aspartic acid
  • aspartic acid [inn]
  • aspartic acid [usan]
  • aspartic acid [usp]
  • aspartic acid [ep]
  • l-aspartic acid [fhfi]
  • aspartic acid [mart.]
  • aspartic acid [mi]
  • l-aspartic acid
  • aspartic acid [inci]
  • l-aspartic acid [fcc]
  • fema no. 3656
  • aspartate
  • aspartic acid [ii]
  • aspartic acid [hsdb]
  • aspartic acid [who-dd]
  • aspartic acid [vandf]
  • nsc-3973
  • deamidated asparagine
ZINC ID(s)
Availability
Present in 96 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT00663624 Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care Phase 4 Withdrawn
NCT01966978 2014-11-01 The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study Phase 4 Recruiting
NCT02269735 2014-11-01 A Two Part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Part II) (MK-2640-001) Phase 1 Recruiting
NCT02276859 2014-10-01 Normal Versus Dual Wave Insulin Bolus for High-protein Food Phase 4 Not Yet Recruiting
NCT02158182 2014-07-01 Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding Phase 4 Recruiting
NCT02101229 2014-05-01 Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital Phase 2/Phase 3 Recruiting
NCT02131246 2014-05-01 A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes Phase 1 Completed
NCT02100475 2014-04-01 A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification Phase 3 Active, Not Recruiting
NCT02089451 2014-03-01 A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects Phase 1 Completed
NCT02043587 2014-01-01 Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma Phase 2 Recruiting
NCT02033239 2014-01-01 A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes Phase 1 Completed
NCT02035371 2014-01-01 A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes Phase 1 Completed
NCT02034513 2014-01-01 A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes Phase 3 Active, Not Recruiting
NCT01722578 2013-12-01 L-ornithine L-aspartate in Overt Hepatic Encephalopathy Phase 4 Recruiting
NCT01992588 2013-11-01 A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01999322 2013-11-01 A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes Phase 3 Completed
NCT02003677 2013-11-01 A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes Phase 1 Completed
NCT01835431 2013-10-01 A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus Phase 3 Completed
NCT01819129 2013-09-01 Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3 Completed
NCT01850615 2013-09-01 Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes Phase 3 Completed
NCT01924637 2013-08-01 A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01831765 2013-08-01 Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes Phase 3 Active, Not Recruiting
NCT01934712 2013-08-01 A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes Phase 1 Completed
NCT01892020 2013-06-01 Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Phase 4 Completed
NCT01814137 2013-03-01 A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily Phase 3 Completed
NCT01848990 2013-03-01 CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Phase 4 Active, Not Recruiting
NCT01713530 2013-02-01 A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin Phase 3 Completed
NCT01773798 2013-01-01 A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01792830 2012-10-01 Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft(CABG) Patients Phase 3 Active, Not Recruiting
NCT01682902 2012-09-01 A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01648218 2012-08-01 Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia Phase 4 Recruiting
NCT01680341 2012-08-01 Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine Phase 3 Completed
NCT01561378 2012-08-01 Cardiac Surgery Neuroprotection Study in Elders Phase 2 Completed
NCT01618214 2012-06-01 Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes Phase 4 Completed
NCT01519674 2012-06-01 Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin Phase 4 Completed
NCT01618188 2012-06-01 A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01510093 2012-05-01 Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II) Phase 2 Completed
NCT01589653 2012-05-01 Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Phase 4 Active, Not Recruiting
NCT01590836 2012-04-01 A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01540812 2012-02-01 Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS Phase 4 Recruiting
NCT01513590 2012-01-01 A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes Phase 3 Completed
NCT01513473 2012-01-01 A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus Phase 3 Completed
NCT01440829 2011-12-01 The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS Phase 2/Phase 3 Completed
NCT01526733 2011-12-01 Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase Phase 4 Completed
NCT00700362 2011-12-01 Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU) Phase 4 Withdrawn
NCT01474538 2011-12-01 Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy Phase 3 Completed
NCT01486966 2011-11-01 Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes Phase 4 Terminated
NCT01469143 2011-11-01 A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01455142 2011-10-01 A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01417897 2011-09-01 Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study Phase 4 Active, Not Recruiting
NCT01388361 2011-09-01 Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin Phase 3 Completed
NCT01427920 2011-09-01 Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes Phase 4 Completed
NCT01678235 2011-09-01 Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus Phase 4 Completed
NCT01445951 2011-09-01 Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period Phase 3 Completed
NCT01365507 2011-06-01 Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens Phase 3 Completed
NCT01407289 2011-06-01 A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia Phase 4 Completed
NCT01333514 2011-04-01 Carbohydrate Consumption as a Factor in Aspart Dosing Phase 4 Completed
NCT01399346 2011-04-01 Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01215435 2011-03-01 Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone Phase 4 Completed
NCT01242826 2011-02-01 Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects Phase 1 Completed
NCT01296438 2011-02-01 A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1 Phase 1 Completed
NCT01275131 2011-01-01 Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM) Phase 1 Completed
NCT01272193 2011-01-01 Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjets With Type 2 Diabetes Phase 3 Completed
NCT01501149 2011-01-01 Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ Phase 4 Recruiting
NCT01278160 2011-01-01 Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756 Phase 4 Completed
NCT01269606 2011-01-01 Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01134107 2010-11-01 Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use Phase 3 Completed
NCT01165684 2010-10-01 Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen Phase 4 Completed
NCT01196104 2010-09-01 Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler Phase 3 Terminated
NCT01190956 2010-09-01 Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: An Extension Trial to NN1250-3585 Phase 3 Completed
NCT01212913 2010-08-01 Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM) Phase 4 Completed
NCT01194245 2010-08-01 Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus Phase 2 Completed
NCT01194258 2010-08-01 Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus Phase 2 Completed
NCT01174303 2010-08-01 A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes Phase 1 Completed
NCT01173926 2010-07-01 Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01293396 2010-06-01 Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids Phase 4 Completed
NCT01138488 2010-06-01 A Trial Investigating the Total Exposure of NN5401 in Children, Adolescents and Adult Subjects With Type 1 Diabetes Phase 1 Completed
NCT01101867 2010-06-01 Prandial Insulin Dosing in Hospitalized Patients Phase 4 Completed
NCT01134224 2010-05-01 A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes Phase 1 Completed
NCT01125553 2010-05-01 A Comparison Between Two Formulations of NN5401 in Healthy Subjects Phase 1 Completed
NCT01123980 2010-05-01 Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment Phase 4 Completed
NCT01121276 2010-04-01 A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes Phase 1 Completed
NCT01121289 2010-04-01 A Trial Investigating NN1218 in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01109316 2010-04-01 Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use Phase 3 Completed
NCT01079234 2010-03-01 Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes Phase 3 Completed
NCT01068652 2010-03-01 Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs Phase 4 Completed
NCT01074268 2010-02-01 Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes Phase 3 Completed
NCT01059812 2010-02-01 A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes Phase 3 Completed
NCT01045447 2010-01-01 Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes Phase 3 Completed
NCT01051102 2010-01-01 Effect of NN5401 in Japanese Subjects With Type 1 Diabetes Phase 1 Completed
NCT01828970 2010-01-01 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase 4 Completed
NCT01045707 2010-01-01 Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes Phase 3 Completed
NCT00791102 2010-01-01 Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC) Phase 2/Phase 3 Completed
NCT01079364 2010-01-01 Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting Phase 4 Terminated
NCT01041755 2009-12-01 Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy. Phase 4 Completed
NCT01009580 2009-11-01 Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes Phase 3 Completed
NCT01028404 2009-11-01 A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes Phase 1 Completed
NCT00992537 2009-10-01 Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics Phase 1 Completed
NCT00993096 2009-09-01 Investigation of the Response Relationship of NN5401 in Type 1 Diabetics Phase 1 Completed
NCT00972283 2009-09-01 Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes Phase 3 Completed
NCT00979875 2009-09-01 A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone Phase 1 Completed
NCT00982228 2009-09-01 Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes Phase 3 Completed
NCT00978627 2009-08-01 Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes Phase 3 Completed
NCT00850161 2009-07-01 Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin Phase 2 Withdrawn
NCT00965549 2009-07-01 Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients Phase 4 Completed
NCT00913497 2009-06-01 The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children Phase 4 Completed
NCT00888732 2009-06-01 A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin Phase 3 Completed
NCT00933673 2009-06-01 New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma Phase 2 Recruiting
NCT00906529 2009-05-01 Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin Phase 4 Recruiting
NCT00942318 2009-03-01 Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes Phase 4 Completed
NCT00821795 2009-02-01 Veterans Inpatient Insulin Study and Transition to Outpatient Therapy Phase 4 Completed
NCT00842361 2009-01-01 Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus Phase 2 Completed
NCT00841087 2009-01-01 Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes Phase 2 Completed
NCT00807092 2008-12-01 Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes Phase 4 Completed
NCT00896831 2008-11-01 Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy Phase 4 Enrolling By Invitation
NCT00797823 2008-11-01 Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone Phase 2 Completed
NCT00785811 2008-10-01 Effect of Chronic Supplementation of L-arginine in the Muscular Performance Phase 4 Terminated
NCT00740142 2008-09-01 Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy Phase 4 Recruiting
NCT01464099 2008-06-01 Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01868581 2008-05-01 Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects Phase 1 Completed
NCT00591227 2008-05-01 Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol. Phase 4 Completed
NCT01868568 2008-04-01 Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes Phase 1 Completed
NCT00657943 2008-04-01 The Copenhagen Insulin and Metformin Therapy Trial Phase 4 Completed
NCT00623194 2008-02-01 Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689 Phase 3 Completed
NCT00627445 2008-02-01 Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes Phase 3 Completed
NCT00614055 2008-01-01 Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes Phase 2 Completed
NCT00613951 2008-01-01 Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes Phase 2 Completed
NCT00612040 2008-01-01 Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes Phase 2 Completed
NCT00607087 2008-01-01 Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus Phase 4 Completed
NCT01868555 2007-12-01 Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects Phase 1 Completed
NCT00969592 2007-11-01 Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers Phase 1 Completed
NCT00669864 2007-11-01 Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin Phase 4 Completed
NCT00537303 2007-10-01 Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes Phase 4 Completed
NCT00537277 2007-10-01 Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs Phase 4 Completed
NCT00581867 2007-10-01 Memory and Insulin in Early Alzheimer's Disease Phase 2 Completed
NCT01159353 2007-09-01 Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart Phase 1 Completed
NCT00542620 2007-09-01 Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial Phase 4 Completed
NCT00523042 2007-08-01 Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma Phase 3 Terminated
NCT00824668 2007-08-01 Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes Phase 1 Completed
NCT00497536 2007-07-01 Pharmacokinetics of IAsp Following CSII in Patients With T1DM Phase 4 Completed
NCT00505882 2007-07-01 Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes Phase 4 Withdrawn
NCT00509925 2007-07-01 Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes Phase 4 Terminated
NCT00998335 2007-06-01 Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes Phase 4 Completed
NCT00469092 2007-05-01 Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes Phase 4 Completed
NCT00346996 2007-05-01 Insulin Analogues and Severe Hypoglycaemia Phase 4 Completed
NCT00472953 2007-05-01 Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Terminated
NCT00467649 2007-05-01 A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes Phase 4 Completed
NCT00474045 2007-05-01 Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes Phase 3 Completed
NCT00473967 2007-05-01 Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults Phase 1 Terminated
NCT00771693 2007-05-01 Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM) Phase 4 Completed
NCT00476437 2007-04-01 Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus. Phase 3 Completed
NCT00449839 2007-04-01 Changes of the Infusion Rate in Insulin Pump Treatment Phase 4 Completed
NCT00447382 2007-03-01 Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes Phase 3 Completed
NCT00825253 2007-03-01 Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes Phase 1 Completed
NCT00435019 2007-02-01 Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes Phase 3 Completed
NCT00434954 2007-02-01 Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes Phase 3 Completed
NCT00590226 2006-12-01 Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes Phase 4 Completed
NCT01865331 2006-12-01 Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects Phase 1 Completed
NCT00393705 2006-10-01 Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) Phase 4 Completed
NCT01865305 2006-09-01 Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes Phase 1 Completed
NCT00331604 2006-08-01 Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes Phase 3 Terminated
NCT00353990 2006-08-01 Bioavailability of Insulin Administered in Duodenum Phase 1/Phase 2 Completed
NCT01538511 2006-06-01 Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers Phase 1 Completed
NCT00322257 2006-05-01 Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes Phase 3 Terminated
NCT01536028 2006-04-01 Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes Phase 1 Completed
NCT00313001 2006-04-01 Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea. Phase 3 Completed
NCT00318786 2006-04-01 Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes Phase 3 Completed
NCT01530048 2006-03-01 Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL) Phase 1 Completed
NCT00282451 2006-02-01 Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes Phase 4 Completed
NCT00309244 2006-02-01 Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up Phase 3 Completed
NCT00267683 2005-12-01 Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes Phase 3 Terminated
NCT01486862 2005-10-01 Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs Phase 4 Completed
NCT00202605 2005-09-01 Safety and Efficacy of SPD465 in Adults With ADHD Phase 2 Completed
NCT00274274 2005-09-01 Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes Phase 4 Completed
NCT00184561 2005-07-01 Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes Phase 4 Completed
NCT00115973 2005-06-01 A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump Phase 1 Completed
NCT00117780 2005-06-01 Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes Phase 4 Completed
NCT01487811 2005-05-01 Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers Phase 1 Completed
NCT00184613 2005-05-01 Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes Phase 1 Completed
NCT00184574 2005-04-01 Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes Phase 3 Completed
NCT00152022 2005-04-01 Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. Phase 3 Completed
NCT00120081 2005-04-01 Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection Phase 1 Completed
NCT00504673 2005-04-01 Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes Phase 3 Completed
NCT00152035 2005-03-01 Safety of SPD465 in Treating Adults With ADHD. Phase 3 Completed
NCT00254085 2005-03-01 Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes. Phase 4 Recruiting
NCT00106366 2005-03-01 Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes Phase 3 Completed
NCT00470314 2005-01-01 Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure Phase 2 Active, Not Recruiting
NCT00097877 2005-01-01 Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes Phase 3 Completed
NCT00150579 2005-01-01 Efficacy and Safety of SPD465 in Adults With ADHD Phase 3 Completed
NCT00494988 2004-12-01 Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart Phase 4 Completed
NCT00184600 2004-11-01 Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes Phase 3 Completed
NCT00101751 2004-10-01 INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study Phase 4 Completed
NCT00097071 2004-10-01 Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents Phase 3 Completed
NCT00461331 2004-10-01 Comparison of Insulins Aspart and Lispro in Insulin Pumps Phase 4 Completed
NCT00097084 2004-09-01 Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes Phase 3 Completed
NCT00184626 2004-09-01 Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. Phase 4 Completed
NCT00095082 2004-09-01 Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes Phase 3 Completed
NCT00097279 2004-08-01 Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes Phase 3 Completed
NCT00747409 2004-07-01 Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes Phase 4 Active, Not Recruiting
NCT00095446 2004-07-01 NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes Phase 4 Completed
NCT00593255 2004-07-01 Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes Phase 4 Completed
NCT00184665 2004-06-01 Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes Phase 3 Completed
NCT00564668 2004-06-01 Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes Phase 3 Completed
NCT00624364 2004-05-01 Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes Phase 4 Completed
NCT00500240 2004-04-01 Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) Phase 3 Terminated
NCT00600366 2004-03-01 Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes Phase 4 Completed
NCT00600626 2004-01-01 Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes Phase 4 Completed
NCT00619697 2003-12-01 Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes Phase 4 Completed
NCT00605020 2003-12-01 Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes Phase 3 Completed
NCT00592969 2003-12-01 Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes Phase 4 Completed
NCT01527656 2003-12-01 Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects Phase 1 Completed
NCT00595374 2003-12-01 Efficacy and Safety of Insulin Detemir in Type 1 Diabetes Phase 3 Completed
NCT00605111 2003-12-01 Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Phase 4 Completed
NCT01527643 2003-11-01 Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects Phase 1 Completed
NCT00280046 2003-11-01 Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes Phase 4 Completed
NCT00082407 2003-11-01 Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin Phase 3 Completed
NCT01620437 2003-11-01 Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects Phase 1 Completed
NCT00433368 2003-10-01 Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy Phase 3 Completed
NCT00612599 2003-09-01 Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes Phase 3 Completed
NCT00571935 2003-08-01 Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes Phase 4 Completed
NCT00617565 2003-07-01 Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes Phase 3 Completed
NCT00791895 2003-06-01 Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs Phase 4 Completed
NCT00604656 2003-05-01 Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes Phase 3 Completed
NCT00572806 2003-02-01 Initiation of Insulin Aspart in Type 2 Diabetes Phase 4 Completed
NCT00853008 2003-01-01 Treatment of High Risk Adult Acute Lymphoblastic Leukemia Phase 4 Recruiting
NCT01486914 2003-01-01 Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process Phase 1 Completed
NCT01527565 2003-01-01 Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects Phase 1 Completed
NCT00121966 2003-01-01 South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus Phase 4 Completed
NCT01527552 2002-11-01 Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects Phase 1 Completed
NCT00598793 2002-11-01 Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy Phase 4 Completed
NCT01527630 2002-11-01 Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects Phase 1 Completed
NCT00597233 2002-10-01 Human Insulin NPH and Insulin Aspart in Type 1 Diabetes Phase 4 Completed
NCT00365170 2002-09-01 Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes Phase 4 Completed
NCT01698697 2002-09-01 Comparison of Two Insulin Aspart Formulations in Healthy Volunteers Phase 1 Completed
NCT00725036 2002-09-01 Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes Phase 3 Completed
NCT01467401 2002-08-01 Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes Phase 4 Completed
NCT00312156 2002-08-01 Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes Phase 3 Completed
NCT01697631 2002-07-01 Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes Phase 4 Completed
NCT01487798 2002-06-01 Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes Phase 4 Completed
NCT00071448 2002-06-01 Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population Phase 3 Completed
NCT01467141 2002-06-01 Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes Phase 4 Completed
NCT01526980 2002-05-01 Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes Phase 2 Completed
NCT00312104 2002-04-01 Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes Phase 3 Completed
NCT00513643 2002-04-01 Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses Phase 1 Completed
NCT01486940 2002-03-01 Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes Phase 3 Completed
NCT01649570 2002-03-01 Safety and Efficacy of Insulin Aspart in Type 2 Diabetes Phase 4 Completed
NCT01486381 2002-03-01 Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes Phase 3 Completed
NCT00676819 2002-01-01 Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes Phase 4 Completed
NCT01527539 2001-11-01 Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Phase 3 Completed
NCT01697657 2001-09-01 Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes Phase 3 Completed
NCT00072904 2001-06-01 Diabetes Therapy to Improve BMI and Lung Function in CF Phase 3 Completed
NCT01526941 2001-05-01 Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01704378 2001-04-01 Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes Phase 4 Completed
NCT01620424 2001-02-01 Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes Phase 1 Completed
NCT01524809 2001-01-01 Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes Phase 1 Completed
NCT01467375 2001-01-01 Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes Phase 3 Completed
NCT01650129 2000-12-01 Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes Phase 3 Completed
NCT00065130 2000-04-01 Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes Phase 3 Completed
NCT01520818 2000-03-01 Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes Phase 3 Completed
NCT01620333 2000-02-01 Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers Phase 1 Completed
NCT00832182 1999-12-01 Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes Phase 3 Completed
NCT01523041 1999-11-01 Comparison of Two Formulations of Biphasic Insulin Aspart 70 Phase 1 Completed
NCT01520831 1999-04-01 Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects Phase 1 Completed
NCT01520753 1999-03-01 Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes Phase 3 Completed
NCT01467323 1998-04-01 Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes Phase 3 Completed
NCT01707134 1997-09-01 Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes Phase 3 Completed
NCT01697618 1997-04-01 Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Phase 2 Completed
NCT01707160 1995-11-01 Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers Phase 1 Completed
NCT00410033 1989-12-01 Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin Phase 3 Completed

(Browse) Purchasable Analogs in ZINC

Products Using Aspartic Acid

Download
APIs Products incorporating these APIs
Alcohol Anti-Aging Hand Sanitizer
Sus Scrofa Skin Pige Ll Real Skin Neck Pack , Pige Ll Real Skin Eye , Pige Ll Real Skin Mask Pack
Glycerin Cliv Barrier Power Ampoule , Perfect Calming , Revitalizing Facial Foam , Anypack Multi Active Hydroge L Eye , Anypack Gold Season Second Skin Hydro Face Mask , Tonymoly Timeless Gf-Factor Toner
Adenosine , Niacinamide Vita Volu Volume Booster , Vitabrid C12 Sensitive Spot Pow Der Serum
Menthol , Salicylic Acid , Panthenol Cellapy Haircell Meso Tonic
Witch Hazel Aqua Barrier Level Up , Aqua Barrier Hydro Softener , Freeze 24 7 Intense Hydrating Face Mask , Leaders Coconut Moisturizing Recovery Mask , Aqua Barrier Lotus Essence Mist , Cellcurin Hair Regen Ampoule , Leaders Insolution Coconut Moisturizing Recovery Mask , Leaders Mediu 2 Step Double Effect Moisturizing Mask , Aquaringer Treatment Mask
Pyrithione Zinc Satinique Anti-Dandruff For Dry, Irritated Scalp
Octisalate , Octinoxate , Titanium Dioxide Snp Animal Tiger Long-Lasting Cover Cushion , Snp Animal Panda Luminous Cover Cushion
Octinoxate , Titanium Dioxide Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Warm Bisque , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Perfect Beige , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Toasty Beige , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 True Beige , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Java , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Gentle Beige , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Cognac , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Cameo , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Vanilla Shell , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Warm Bronze , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Warm Sunbeige , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Bisque , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Buff , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Cocoa , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Warm Honey , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Beige , Ceramide Lift And Firm Makeup Broad Spectrum Sunscreen Spf 15 Mocha
Zinc Oxide , Titanium Dioxide Premium Gold Mineral Bb , Missha M Signature Real Complete Bb Spf25 Pa Plus Plus , Missha M Signature Real Complete Bb Honey Beige , Aqua Aura Moist Finish Pact , Premium Gold Mineral Bb
Avobenzone , Octinoxate Adaptasun Sun Care Face Spf 15 , Adaptasun Sun Care Sea And Tropics Face Spf 25
Avobenzone , Octinoxate , Oxybenzone Oraser Daily Hand Repair Broad-Spectrum Spf 20 Sunscreen , Anew Clinical Absolute Even Spot Correcting Hand
Glycerin , Yellow Wax Tonymoly Intense Care Gold Syn-Ake Wrinkle Cream
Octisalate , Octinoxate , Titanium Dioxide , Oxybenzone Guinot Skin Defense Spf 15 Face , Lbel Protege Expert , Lbel Protege Expert
Adenosine , Niacinamide , Panthenol Vita Volu 101 Essence
Dimethicone Skinpia 10 Skin Shield Renewal , G9 Whitening , Mini Bling Pocket Hair Pack , Mederma Pm
Zinc Oxide G9 Whitening Skin
Adenosine Niveola 3d Animal Cat Mask Pack , Dr. Althea Water Glow Aqua Ampoule Mask
Ascorbic Acid Dr Cellapy Sr Premium
Avobenzone , Octinoxate , And Oxybenzone Zo Skin Health Oraser Anti-Aging Hand Care Program Correct, Protect And Prevent Aging Hands
Octisalate , Homosalate , Octocrylene , Avobenzone Lipidol , Lipidol
Titanium Dioxide Missha M Watery B.b Spf 27
Zinc Oxide , Octinoxate , Titanium Dioxide Iope Air Cushion Flawless 21n , Iope Air Cushion Perfection C13 , Iope Air Cushion Matte Longwear C13 , Iope Air Cushion Sheer 23w
Dimethicone , Glycerin Tonymoly Timeless Gf-Factor Emulsion , Tonymoly Timeless Gf-Factor Cream , Tonymoly Intense Care Gold Syn-Ake Wrinkle Perfector
Rosemary Zippity Doos Styling For Children

Dosages

Route Formulation Per Unit Dose
Iv(infusion) Injection 0.68%
Iv(infusion) Powder, For Injection Solution, Lyophilized, With Additives

More Information

Usage Over Time

Comments